Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity.

From January to July 1991, an outbreak of mumps occurred in Maury County, Tennessee. At the primarily affected high school, where 98% of students and all but 1 student with mumps had been vaccinated before the outbreak, 68 mumps cases occurred among 1116 students (attack rate, 6.1%). Students vaccinated before 1988 (the first year mumps vaccination was required for school attendance in Tennessee) may have been at greater risk of mumps than those vaccinated later (65[6.1%] of 1001 vs. 2[2.2%] of 89; risk ratio, 2.9; 95% confidence interval, 0.7-11.6). Of 13 persons with confirmed mumps who underwent serologic testing, 3 lacked IgM antibody in well-timed acute- and convalescent-phase serum specimens. Vaccine failure accounted for a sustained mumps outbreak in a highly vaccinated population. Most mumps cases were attributable to primary vaccine failure. It is possible that waning vaccine-induced immunity also played a role.

[1]  L. Bell,et al.  Secondary measles vaccine failure in healthcare workers exposed to infected patients. , 1993, Infection control and hospital epidemiology.

[2]  Laura H. Kahn,et al.  Mumps outbreak in a highly vaccinated population. , 1991, The Journal of pediatrics.

[3]  Robert T. Chen,et al.  Measles antibody: reevaluation of protective titers. , 1990, The Journal of infectious diseases.

[4]  J. P. Davis,et al.  Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. , 1990, JAMA.

[5]  P. Fine,et al.  Duration of live measles vaccine-induced immunity. , 1990, The Pediatric infectious disease journal.

[6]  W. Schaffner,et al.  A large outbreak of mumps in the postvaccine era. , 1988, The Journal of infectious diseases.

[7]  S. Cochi,et al.  Perspectives on the relative resurgence of mumps in the United States. , 1988, American journal of diseases of children.

[8]  M. French,et al.  Adaptation of a commercially available indirect fluorescent antibody slide test for measuring measles-specific immunoglobulins. , 1986, Diagnostic microbiology and infectious disease.

[9]  Y. Ito,et al.  Enzyme-linked immunosorbent assay for mumps IgM antibody: comparison of IgM capture and indirect IgM assay. , 1985, Journal of virological methods.

[10]  R. Kim-Farley,et al.  Clinical mumps vaccine efficacy. , 1985, American journal of epidemiology.

[11]  F. Black,et al.  Reported measles in persons immunologically primed by prior vaccination. , 1982, The Journal of pediatrics.

[12]  P. Krause,et al.  Measles revaccination. Persistence and degree of antibody titer by type of immune response. , 1978, American journal of diseases of children.

[13]  R. Gilfillan,et al.  Acute parotitis associated with influenza type A: a report of twelve cases. , 1977, The New England journal of medicine.

[14]  J. Phair,et al.  Measles IgM response during reinfection of previously vaccinated children. , 1973, The Journal of pediatrics.

[15]  L. Lobes,et al.  Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. , 1972, The Journal of pediatrics.

[16]  M. Mufson,et al.  Acute parotitis associated with parainfluenza 3 virus infection. , 1970, American journal of diseases of children.

[17]  J. Pagano,et al.  Field evaluation of live virus mumps vaccine. , 1968, The Journal of pediatrics.

[18]  M. Hilleman,et al.  Live, attenuated mumps-virus vaccine. , 1968, The New England journal of medicine.

[19]  J. Howlett,et al.  A new syndrome of parotitis with herpangina caused by the Coxsackie virus. , 1957, Canadian Medical Association journal.